Project: CANCER MULTI-OMICS AVATARS FOR INTEGRATED PRECISION MEDICINE
Acronym | LANTERN (Reference Number: ERAPERMED2022-116) |
Duration | 01/04/2023 - 31/03/2026 |
Project Topic | Lung cancer is one of the most commonly diagnosed forms of cancer worldwide, accounting for approximately 12.2% of total cancer diagnoses. Despite the recent advances in treatment, prognosis still remains poor with a high mortality rate. The current therapeutic approaches have reached a significantly high level of complexity, due to the recent identification of mutations and other cancer heterogeneity drivers (i.e., actionable mutations or PD-L1 expression for immunotherapy indication), thereby complicating the process of decision-making by clinicians. The integration of "omics" datasets in different domains (i.e., genomics, proteomics) may further support clinicians in identifying innovative variables to support a new kind of comprehensive cancer care, towards personalized medicine. In the last decade, significant improvements have been observed in the development of omics technologies, resulting in an overwhelming number of variables to be considered while making decisions that can be hardly handled by a human operator. Interestingly, with the advent of advanced Artificial intelligence (AI) techniques, more information can be obtained via "Internet of Things" technologies and various omics datasets which could be used efficaciously in creating predictive models. These models can be used can be used either individually or merged in a multi-omics patient avatars to assist in the clinical decision-making process and introduce new paradigms of care and research, evaluating unexpected links among variables that were previously unexplored. Therefore, the primary aim of the LANTERN project is to develop accurate predictive models for lung cancer patients, using various omics-based variables and integrating well-established clinical factors with "big data" and advanced imaging features. With this, individual patient avatars can be created which will serve as powerful tools in guiding clinicians and researchers in making more accurate decisions. |
Network | ERA PerMed |
Call | 5th Joint Transnational Call for Proposals (2022) |
Project partner
Number | Name | Role | Country |
---|---|---|---|
1 | Fondazione Policlinico Universitario “A. Gemelli” IRCCS | Coordinator | Italy |
2 | University of Debrecen | Partner | Hungary |
3 | Hospital de la Santa Creu i Sant Pau | Partner | Spain |
4 | Accademia del Paziente Esperto EUPATI - AdPEE | Partner | Italy |
5 | Technisce Universität Dresden | Partner | Germany |
6 | Koç University | Partner | Türkiye |